Search OFIX
Orthofix Medical Inc.
Nasdaq · CIK 884624
Last close9.09
Daily change-0.12 (-1.30%)
10 Years gain-78.36%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
OFIX · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1223
Fundamental
34.6Momentum
94.4Acceleration
92.0Confidence
91.0Annual Revenue17
Quarterly Revenue69
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth16.4 / 25
Quality5.4 / 25
Capital Efficiency1.7 / 20
Balance Sheet9.3 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 4.0036 percentage points.
Operating leverageOperating margin improved by 8.8809 percentage points.
ROIC expansionROIC improved by 7.654 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM5.01%OK
Revenue CAGR 3Y21.3%OK
Gross Margin70.71%OK
Operating Margin-6.81%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-7.56%OK
Incremental Operating Margin 3Y-17.63%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y4.38%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $822.31M | $566.02M | -$81.43M | $33.35M | -$1.28M | 68.83% | -9.9% | -0.16% | -11.67% | 39.6M |
| 2025 FY Dec 31, 2024 | $799.49M | $545.89M | -$84.62M | $25.79M | -$9.09M | 68.28% | -10.58% | -1.14% | -10.81% | 38.13M |
| 2025 FY Dec 31, 2023 | $746.64M | $486.27M | -$139.11M | -$45.75M | n/a | 65.13% | -18.63% | n/a | -23.23% | 36.73M |
| 2024 FY Dec 31, 2022 | $460.71M | $337.17M | -$13.27M | -$11.54M | n/a | 73.18% | -2.88% | n/a | -3.92% | 20.05M |
| 2023 FY Dec 31, 2021 | $464.48M | $349.57M | -$8.32M | $18.48M | $690,000.00 | 75.26% | -1.79% | 0.15% | -2.58% | 19.69M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $816.40M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-333822, 0001193125-25-263670 |
| Revenue Growth TTM | 5.01% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-333822, 0001193125-25-263670 |
| Revenue CAGR 3Y | 21.3% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-065189 |
| Revenue CAGR 5Y | 15.13% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-065189 |
| Gross Profit CAGR 3Y | 18.85% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-065189 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-333822, 0001193125-25-263670 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 70.71% | Gross Profit / Revenue | OK | 0001193125-26-333822, 0001193125-25-263670 |
| Operating Margin | -6.81% | Operating Income / Revenue | OK | 0001193125-26-333822, 0001193125-25-263670 |
| ROIC | -7.56% | NOPAT / Average Invested Capital | OK | 0001193125-26-333822, 0001193125-25-263670 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-333822 |
| Current Ratio | 2.84x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.47x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-333822 |
| Revenue per Diluted Share | $19.96 | Revenue / Diluted Shares | OK | 0001193125-26-333822, 0001193125-25-263670 |